Companies and Salix Pharmaceuticals acknowledged that the Centers for Medicare and Medicaid Services has selected XIFAXAN ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Bausch + Lomb Corporation (BLCO – Research Report) today and set a price target ...

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products.

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, issued the following ...

Shares in ophthalmology specialist Bausch + Lomb (B+L) have lost almost 10% of their value on a report that a joint takeover bid for the group is in trouble. The Financial Times has said that ...

LAVAL, QC / ACCESSWIRE / December 5, 2024 / Bausch Health Companies Inc. (NYSE ... Salix has partnered with influencers to spread the word online using the hashtag #vOICesOfOIC, launched a content ...

Bausch Health Companies Inc. (TSE:BHC – Get Free Report) shares rose 3% during mid-day trading on Thursday . The company traded as high as C$11.67 and last traded at C$11.61. Approximately 76,142 ...

The campaign will spotlight educational resources and share stories of individuals and families living with glaucoma to raise ...